Atea Pharmaceuticals
AVIR
#7534
Rank
HK$2.18 B
Marketcap
HK$25.91
Share price
-0.89%
Change (1 day)
15.16%
Change (1 year)

Earnings for Atea Pharmaceuticals (AVIR)

Earnings in 2024 (TTM): -HK$1.37 Billion

According to Atea Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$1.05 Billion a decrease over its 2022 earnings that were of -HK$0.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atea Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$1.37 Billion30.33%
2023 -HK$1.05 Billion12.92%
2022 -HK$0.93 Billion-186.22%
2021 HK$1.07 B-1366.01%
2020 -HK$85.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.98 Billion-28.49%๐Ÿ‡บ๐Ÿ‡ธ USA